Work-Health-Life-Balance - Mental Resilience, Stability & Healthy Nutrition

Sponsor
Medical University of Graz (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05489835
Collaborator
(none)
200
1
28
7.1

Study Details

Study Description

Brief Summary

New working environments (digitalization, flexibilization) can lead to increased levels of stress. A balanced work-life balance is therefore important in order to prevent negative effects of stress on mental health.

This study investigates,

  1. how stress, recovery, nutritional behavior, resilience and sleep behavior are related to the changed working conditions.

  2. how standardized nutritional training affects individual body composition (measured using Bioelectrical Impedance Analyses, BIA), stress perception, burn-out symptoms and sleep.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Nutritional counseling

Detailed Description

The ways of working must adapt to the challenges and opportunities of the digital world. Work 4.0 describes the process of change in the working environment in the digital age. Adapting to rapidly changing and sometimes uncertain living and working conditions in times of digitization, dislocated working (including "home office") and altered work processes demands a considerable effort of resources from numerous employees. Previously established work environments and behaviors are being evaluated and adapted to the new circumstances and requirements.

Such times of change often cause uncertainty and result in increased stress levels. Stress, in turn, leads to a variety of symptoms in many areas of life and work, which can limit the ability to work. As a result, successful adaptation to the challenges of the new work reality of Work 4.0 can fail.

Research Questions:

This study investigates,

  1. how stress, recovery, nutritional behavior, resilience and sleep behavior are related to the changed working conditions and central characteristics of work 4.0.

  2. how standardized nutritional training based on the Austrian Food Pyramid affects individual body composition (measured using Bioelectrical Impedance Analyses, BIA), stress perception, burn-out symptoms and sleep.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Work-Health-Life-Balance 4.0 - Mental Resilience, Stability & Healthy Nutrition in a New Work Reality
Anticipated Study Start Date :
Aug 30, 2022
Anticipated Primary Completion Date :
Jun 30, 2024
Anticipated Study Completion Date :
Dec 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Employees

Employees in Austrian companies affected by digitalization

Behavioral: Nutritional counseling
Nutritional counseling

Outcome Measures

Primary Outcome Measures

  1. Stress [3 months]

    Stress-Erholungsfragebogen (RESTQ); minimum value: 0, maximum value: 294; High scores reflect high subjective stress.

Secondary Outcome Measures

  1. Sleep [3 months]

    Insomnis severity index: minimum value: 0, maximum value: 28; High scores reflect the presence of sleeping disorders

  2. Body mass index [3 months]

    Body mass index (BMI); BMI= body weight / (body height)²

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • employees in austrian companies affected by digitalization

  • Informed consent

Exclusion Criteria:
  • no informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Graz Graz Styria Austria 8036

Sponsors and Collaborators

  • Medical University of Graz

Investigators

  • Principal Investigator: Andreas Baranyi, M.D., Medical University of Graz, Auenbruggerplatz 31, 8036 Graz, Austria

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andreas Baranyi, Assoc. Prof. Dr., Medical University of Graz
ClinicalTrials.gov Identifier:
NCT05489835
Other Study ID Numbers:
  • EK 34-147 ex 21/22
First Posted:
Aug 5, 2022
Last Update Posted:
Aug 5, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 5, 2022